Clinical trial Recruiting at 1 site Observational Ages Any age to 17

Blood Transfusion Factors and Cell Saver Use in Kids’ Spine Surgery

Official title: Risk Factors for Homologous Blood Transfusion and Impact of Cell Saver Use in Pediatric Scoliosis Surgery: A Retrospective Monocentric Study

Run by Tunis University · NCT07661589 · Data updated 2026-11-12

This study looks at which factors put pediatric scoliosis patients at risk for needing donor blood during posterior spinal fusion and how using a Cell Saver during surgery might reduce that need.

More Scoliosis trials

Quick facts

Study typeObservational
AgesAny age to 17 Years
SexAll
Enrollment200 (estimated)
SponsorTunis University
Academic / other
Locations1 site (Tunis)
StatusRecruiting
StartedApril 1, 2023
Main results expectedMarch 2, 2026
Study endsDecember 31, 2026
Registry record updatedJune 22, 2026
Trial IDNCT07661589 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are children under 18 undergoing planned posterior instrumented spinal fusion for scoliosis.

Probably not a fit

Patients not receiving homologous transfusions or not treated with Cell Saver may have limited applicability of the findings.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a retrospective observational study in children undergoing posterior instrumented spinal fusion for scoliosis. It aims to identify preoperative and intraoperative factors associated with homologous red blood cell transfusion and to quantify how much Cell Saver autologous reinfusion lowers the need for donor blood. Data will come from pediatric patients under 18 treated at Bechir Hamza Children Hospital in Tunis. The study excludes revisions, known clotting disorders, non-orthopedic spine surgeries, and cases with missing transfusion data. The findings could inform blood-conservation strategies and transfusion planning in pediatric spine procedures.

Why it matters

Potential benefit: If successful, the study could help clinicians tailor blood-conservation strategies to individual patients and reduce exposure to donor blood.

How similar studies have gone: Previous work in similar adult and pediatric settings suggests potential benefits of Cell Saver use and risk-factor identification, but pediatric data remain limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patient aged under 18 years (\< 18 years old).
* Programmed surgical correction for scoliosis (including idiopathic, neuromuscular, and congenital etiologies).
* Instrumented surgery involving posterior spinal arthrodesis.

Exclusion Criteria:

* Revision spine surgeries.
* Known constitutional hemostasis disorders.
* Non-orthopedic spine surgeries.
* Missing core clinical or transfusion data.

Where it's running

  • Bechir Hamza Children Hospital
    Tunis, Tunisia
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.